title: ΓΡΑΠΤΗ ΕΡΩΤΗΣΗ αρ θ. 955/98 του Gianfranco DELL'ALBA προς την Επ τροπή. Πρόγραμμα UNDCP στο Αφγανιστάν

text: 9. 10. 98 EL Epi·shmh Efhmeri·da tvn Eyrvpai¤kv· n Koinoth·tvn C 310/149 Apa· nthsh toy k. Mar(cid:14)·n ej ono·matow thw Epitroph· w (21 Aprili·oy 1998) H i·dia h Koino·thta den e·xei armodio·thta sxetika· me to ue·ma toy xre·oyw sto opoi·o anafe·retai to ajio·timo me·low toy Koinoboyli·oy. H Epitroph· den mporei· synepv· w na energh·sei apeyuei·aw o·son afora· th diagrafh· toy ypoloi·poy kai thn ejyphre·thsh toy ejvterikoy· xre·oyw thw Nikara· goyaw. H Epitroph·, vsto·so, pistey·ei o·ti h epiba·rynsh poy yfi·statai h Nikara·goya apo· to xre·ow apotelei· ejairetika· mega·lo ba·row gi(cid:146)ayth· thn ejairetika· ftvxh· xv· ra thw Kentrikh·w Amerikh·w. H Epitroph· symmeri·zetai thn a·poch toy ajio·timoy me·loyw toy Koinoboyli·oy o·ti ta posa· se syna·llagma poy ei·nai ypoxrevme·nh na kataba·llei ethsi·vw h Nikara·goya prow ejyphre·thsh toy xre·oyw ei·nai ejairetika· ychla·. Sto plai·sio ayto·, h shmantikh· synergasi·a thw Koino·thtaw se poiki·loyw tomei·w e·xei xvri·w amfiboli·a makrooikonomike·w epiptv· seiw sto baumo· poy symba·llei sthn ejisorro·phsh thw synolikh·w oikonomikh·w kata·stashw thw xv· raw. (98/C 310/206) GRAPTH ERVTHSH P-0955/98 ypobolh· : Gianfranco Dell(cid:146)Alba (ARE) prow thn Epitroph· (16 Marti·oy 1998) Ue·ma: Pro·gramma UNDCP sto Afganista·n (cid:201)xontaw ypo·ch o·ti to Eyrvpai¤ko· Koinoboy·lio ene·krine omofv· nvw, stiw 19 Febroyari·oy 1998, koino· ch·fisma gia thn kata·stash sto Afganista·n, me to opoi·o ekto·w toy o·ti epanalamba·nei «thn aysthrh· katadi·kh toy kauestv· tow tvn Talimpa·n kai thw politikh·w tvn systhmatikv· n parabia·sevn tvn anurvpi·nvn dikaivma·tvn poy efarmo·zei» (par. 1), yiouetei· mia ejairetika· kritikh· sta·sh sxetika· me thn politikh· kai dhmokratikh· skopimo·thta, alla· kai thn apotelesmatiko·thta toy progra· mmatow poy ue·lei na ylopoih·sei sto Afganista·n to UNDCP (Pro·gramma tvn Hnvme·nvn Eunv· n gia ton Dieunh· (cid:201)legxo tvn Narkvtikv· n). To pro·gramma ayto· proble·pei th dia·uesh xrhmatodotikv· n pistv· sevn sto kauestv· w tvn Talimpa·n v· ste na jekinh·sei h proodeytikh· ekri·zvsh tvn kalliergeiv· n opi·oy. Sthn aitiologikh· ske·ch I, to EK epibebaiv· nei en prokeime·nv o·ti «to kauestv· w tvn Talimpa·n den diaue·tei kamia· dieunh· nomimo·thta», env· sthn aitiologikh· ske·ch Z yposthri·zei o·ti «mo·no mia diarkh·w eirh·nh sthn perioxh· ua epitre·cei thn ekri·zvsh toy empori·oy aytoy· (toy opi·oy)». Kata· syne·peia, to EK ekfra·zei (sthn par. 8) «thn anhsyxi·a toy gia th symfvni·a poy synh·fuh metajy· UNDCP kai tvn Talimpa·n» kai kalei· «thn Epitroph· kai ta kra·th me·lh na ejeta· soyn ek toy sy·neggyw tiw sygkekrime·new leptome·reiew efarmogh·w thw en lo·gv symfvni·aw», gia na zhth·sei (sthn par. 9) «na diathrhuei·, me thn ejai·resh thw anurvpistikh·w boh·ueiaw, h diakoph· ka·ue boh·ueiaw h· progra·mmatow synergasi·aw e·vw o·toy gi·noyn sebasta· apo· thn kybe·rnhsh toy Afganista·n ta anurv· pina dikaiv· mata tvn andrv· n kai tvn gynaikv· n». (cid:201)xontaw ypo·ch o·ti o Antipro·edrow thw Epitroph·w k. Marin, dh·lvse sthn olome·leia o·ti: «xvri·w a·llo kai emei·w, mazi· me to Eyrvpai¤ko· Koinoboy·lio, symmerizo·maste tiw amfiboli·ew o·son afora· th bivsimo·thta toy progra·mmatow gia th mega·lhw kli·makaw antikata·stash tvn kalliergeiv· n poy protei·nei to UNDCP. den nomi·zoyme o·ti ayth· th stigmh· h kata·stash sto Afganista·n afh·nei periuv· ria gia thn efarmogh· eno·w enallaktikoy· anaptyjiakoy· progra·mmatow me sto·xo thn katapole·mhsh thw kallie·rgeiaw thw mh·kvnow thw ypnofo·roy». (cid:201)xontaw ypo·ch o·ti h EE kai ta kra·th me·lh ei·nai oi ky·rioi xorhgoi· tvn programma·tvn toy UNDCP, ti syne·xeia proti·uetai na dv· sei h· e·xei h·dh dv· sei h Epitroph· sth sygkekrime·nh ayth· ue·sh toy EK; Sygkekrime·na, ei·nai se ue·sh h Epitroph· na maw diabebaiv· sei o·ti kami·a eidikh· koinotikh· eisfora· den ua douei· gia th xrhmatodo·thsh toy en lo·gv progra·mmatow; Apa· nthsh toy k. Marin ej ono·matow thw Epitroph· w (2 Aprili·oy 1998) H Epitroph· e·xei amfiboli·ew, o·pvw kai to Koinoboy·lio, sxetika· me thn skopimo·thta toy progra·mmatow tvn Hnvme·nvn Eunv· n gia to Dieunh· (cid:201)legxo tvn Narkvtikv· n (UNDCP) sto Afganista·n, ka·tv apo· tiw shmerine·w synuh·kew. Sthn pra·jh ta kra·th me·lh ekfra·zoyn tiw i·diew amfiboli·ew kai vw ek toy·toy h Koino·thta ene·krine pro·sfata odhgi·ew gia toyw xorhgoy·w boh·ueiaw oi opoi·oi proti·uentai na sthri·joyn e·rga toy UNDCP. Sy·mfvna me tiw odhgi·ew ayte·w oi xorhgoi· boh·ueiaw «ua prospauh·soyn na ejasfali·soyn thn efikth· kai oysiastikh· ekri·zvsh tvn kalliergeiv· n paparoy·naw» kai ypenuymi·zoyn sta Hnvme·na (cid:201)unh th shmasi·a na lhfuoy·n ypo·ch oi anhsyxi·ew tvn xorhgv· n boh·ueiaw sxetika· me to pro·gramma UNDCP, dedome·noy o·ti ta sxe·dia toy pre·pei na ei·nai symbata· me tiw eyry·terew politike·w kai sto·xoyw tvn HE ston tome·a thw paroxh·w boh·ueiaw sto Afganista·n, kai na lamba·noyn ypo·ch toyw ta anurv· pina dikaiv· mata kai ta ue·mata poy aforoy·n th gynai·ka. »


title: 98/256/EC: Council Decision of 16 March 1998 concerning emergency measures to protect against bovine spongiform encephalopathy, amending Decision 94/474/EC and repealing Decision 96/239/EC

eurovoc_concepts:
United Kingdom
animal disease
cattle
export restriction
health risk
veterinary inspection

formats: html pdf print

text: L 113/32 ‹ EN ‹ Official Journal of the European Communities 15. 4. 98 II (Acts whose publication is not obligatory) COUNCIL COUNCIL DECISION of 16 March 1998 concerning emergency measures encephalopathy, spongiform amending Decision 94/474/EC and repealing Decision to protect against bovine 96/239/EC (98/256/EC) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 90/425/EEC of 26 June 1990 concerning veterinary and zootechnical checks applicable in intra-Community trade in certain live animals and products with a view to the completion of the internal market (1), and in particular Article 10(4) thereof, Having regard to Council Directive 89/662/EEC of 11 December 1989 concerning veterinary checks in intra-Community trade with a view to the completion of the internal market (2), and in particular Article 9(4) thereof, Having regard to the proposal from the Commission, (1) Whereas new information has been published in the United Kingdom further supporting the hypothesis that exposure to the bovine spongiform encephalo- pathy (BSE) agent is linked to the new variant of Creutzfeldt Jacob Disease (CJD) in humans; whereas on 16 September 1997 the Spongiform Encephal- opathy Advisory Committee (SEAC) of the United Kingdom concluded that recent research provided (1) OJ L 224, 18. 8. 1990, p. 29. Directive as last amended by Directive 92/118/EEC (OJ L 62, 15. 3. 1993, p. 49). (2) OJ L 395, 30. 12. 1989, p. 13. Directive as last amended by Directive 92/118/EEC. the agent which compelling new evidence that causes BSE is identical to the agent which causes the new variant of CJD in humans; whereas on 18 September 1997 the Advisory Committee on Dangerous Pathogens (ACDP) concluded that the BSE agent should now be classified as a human pathogen; (2) Whereas, in those circumstances and as an emer- gency measure, it is appropriate to prohibit tempor- arily the dispatch to the other Member States of all bovine animals from the United Kingdom and of all products consisting entirely or in part of, or incorp- orating materials derived from, bovine animals slaughtered in the United Kingdom which are liable to enter the human food or animal feed chains or are destined for use in cosmetic, pharmaceutical or medical products; whereas in order to prevent deflec- tions of the same prohibitions should also apply to exports to third countries; trade, (3) Whereas, in order to protect animal and human health in the Community, the Commission adopted Decision 94/474/EC of 27 July 1994 concerning certain protection measures relating to bovine spon- giform encepahalopathy and repealing Decisions 89/469/EEC Decision 92/290/EEC of 14 May 1992 concerning certain 90/200/EEC (3), and (3) OJ L 194, 29. 7. 1994, p. 96. Decision as last amended by Decision 95/287/EC (OJ L 181, 1. 8. 1995, p. 40). 15. 4. 98 ‹ EN ‹ Official Journal of the European Communities L 113/33 June 1994 protection measures relating to bovine embryos in respect of bovine spongiform encephalopathy (BSE) in the United Kingdom (1), Decision 94/381/EC of 27 certain protection concerning measures with regard to bovine spongiform encepha- lopathy and the feeding of mammalian derived protein (2) and Decision 96/449/EC of 18 July 1996 on the approval of alternative heat-treatment systems for processing animal waste with a view to the inacti- vation of spongiform encephalopathy agents (3); (4) Whereas the United Kingdom has taken measures as a result of the publication of information on certain cases of CJD in that Member State; (5) Whereas the United Kingdom has banned the use of mammalian meat-and-bone meal, regardless of its origin, for feeding farm animals; whereas it is neces- sary to provide that mammalian meat-and-bone meal and farm animal feed and fertilisers containing mammalian meat-and-bone meal, which by their nature could enter the farm animal feed chain, may not be dispatched from the United Kingdom; (6) Whereas the risk of transmissible spongiform ence- phalopathies (TSEs) entering the human food or animal feed chains through the consumption of protein derived from domestic carnivores is con- sidered low; whereas that risk can be further reduced by requiring that domestic carnivores are not fed mammalian meat-and-bone meal originating in the United Kingdom; whereas it is therefore appropriate to provide that food for domestic carnivores which is produced in the United Kingdom but contains no mammalian meat-and-bone meal originating in that country may be dispatched from its territory to other Member States or to third countries; (7) Whereas the United Kingdom has taken measures to destroy certain bovine tissues; (8) Whereas Commission Decision 96/239/EC of 27 March 1996 on emergency measures to protect against bovine spongiform encephalopathy (4), before its amendment by Decision 96/362/EC (5), prohibited the dispatch from the United Kingdom to other (1) OJ L 152, 4. 6. 1992, p. 37. Decision as amended by the 1994 Act of Accession. (2) OJ L 172, 7. 7. 1994, p. 23. Decision as amended by Decision 95/60/EC (OJ L 55, 11. 3. 1995, p. 43). (3) OJ L 184, 24. 7. 1996, p. 43. (4) OJ L 78, 28. 3. 1996, p. 47. (5) OJ L 139, 12. 6. 1996, p. 17. Member States and to third countries, in particular, of bovine semen, and certain other products from the United Kingdom obtained from bovine animals slaughtered in the United Kingdom which are liable to enter the animal feed or human food chains and materials destined for use in medicinal products, cosmetics or pharmaceutical products; (9) Whereas the Scientific Veterinary was consulted on 18 and 26 April 1996; whereas, in the opinion of that Committee, bovine semen is considered to be safe for animal health with respect to BSE; (10) Whereas the Scientific Committee on Cosmetology was consulted on the safety of certain bovine products on 11 April 1996; whereas the Liaison Committee of European Associations of the Perfume, Cosmetic Products and Toiletries Industries (Colipa) has recommended its members not to use source materials from United Kingdom bovine animals; whereas its recommendation; whereas members Commission Directive 97/1/EC of 10 January 1997 adapting to technical progress Annexes II, III, VI, and VII to Council Directive 76/768/EEC on the approximation of the laws of the Member States re- lating to cosmetic products (6), has provisionally pro- hibited the placing on the market of cosmetic products containing certain tissues and fluids; that Committee has declared that follow that (11) Whereas food was the Scientific Committee for consulted on the safety of certain bovine products on 15 April 1996; (12) Whereas the Committee for Proprietary Medicinal Products was consulted on 16 April 1996; whereas the pharmaceutical sector had already introduced measures relating to the sourcing of materials and their treatment; whereas every medicinal product is undergoes a pre-marketing approval before it placed on the market by virtue of which the treat- ment process of any raw material is evaluated; whereas at the request of the European Agency for the Evaluation of Medicinal Products, all Community marketing authorisation holders, or applicants with a positive opinion from the Committee for Proprietary Medicinal Products or the Committee for Veterinary Medicinal Products, have the products concerned do not contain bovine tissue of United Kingdom origin; confirmed that (6) OJ L 16, 18. 1. 1997, p. 85. L 113/34 ‹ EN ‹ Official Journal of the European Communities 15. 4. 98 (13) Whereas subsequently, additional information was made available in order to facilitate a more complete risk assessment; whereas, on that basis, the Scientific Veterinary Committee on 26 April 1996 concluded that a combination of appropriate sourcing of bovine materials used and the application of minimum processing standards whch have been shown effect- ively to inactivate the BSE agent together give good reassurances about the safety of those materials for the food or cosmetic use; whereas, consequently, Scientific Veterinary Committee has recommended safety parameters for the production of those ma- terials which are therefore considered to be safe; whereas, however, in order to regualarise the situ- ation, pending further scientific knowledge and advice, it is appropriate to withdraw the possibility of dispatch of gelatin made from raw materials from bovine animals slaughtered in the United Kingdom for human food, animal feed, cosmetics pharmaceu- tical and medical purposes; whereas that is in con- formity with the advice from the Multidisciplinary Scientific Committee of 3 April 1997, according to which no production can be considered safe if the base material used for gelatin production is poten- tially infectious; (14) Whereas the Commission accordingly considered that certain products, such as gelatin and tallow, were safe; (20) Whereas the United Kingdom should be permitted to dispatch rom its territory gelatin and di-calcium phosphate for technical purposes made from raw from bovine animals slaughtered in the material United Kingdom, provided that it is suitably labelled; (15) Whereas in 1988 the United Kingdom introduced a for animals affected with BSE to be requirement completely destroyed; whereas the Council, at its meeting on 1, 2 and 3 April 1996, concluded that bovine animals over the age of 30 months should not enter the human food or animal feed chains or be used for cosmetic or pharmaceutical products; whereas such animals should not be used as source materials for certain bovine products; (16) Whereas furthermore, certain bovine tissues should not be used as source materials for those products; (17) Whereas Decision 96/362/EC amended Decision 96/239/EC to exempt certain products, such as gelatin, tallow and bovine semen, from the prohibi- tion; (18) Whereas the Scientific Veterinary Committee at its meeting on 17 July 1996 endorsed the report of the sub-group for BSE of 26 June 1996, where it recom- mended that for gelatin es- the risk assessment tablished by the Scientific Veterinary Committee on 26 April 1996 be reappraised in the light of the uncertainties as to the inactivation of the BSE agent, due note being taken of the requirements of De- cision 96/362/EC; (21) Whereas the United Kingdom should also be permitted to disptach from its territory gelatin produced from raw material from bovine animals not slaughtered in the United Kingdom; whereas the United Kingdom has introduced a system of trace- ability for such gelatine to ensure that the origin of the raw material is identifiable; whereas the Com- munity rules should be supplemented by formally introducing a system of traceability; whereas such a system should be introduced for other products which are exempted from the overall ban; whereas a system of labelling should also be introduced; (22) Whereas it is necessary to provide that products from bovine animals not slaughtered in the United Kingdom should come from approved establish- ments under official veterinary control which have a system in place to ensure traceability to the origin of the raw materials; whereas, however, dispatch of those products from the United Kingdom may take place inmediately, without prior inspection by the Commission; is necessary to lay down appropriate (23) Whereas it guarantees the dispatch from the United for Kingdom of certain products obtained from bovine animals which were not slaughtered in the United Kingdom; (19) Whereas Decision 96/362/EC laid down certain preconditions which had to be met before the United Kingdom could dispatch from its territory gelatin made from raw materials from bovine animals; whereas those preconditions have not beeen fulfilled and such dispatch has not been authorised; (24) Whereas a reliable system of controls throughout the Community is a precondition for the smooth func- tioning of the beef market; whereas it is clear from the investigations by the Unit on Coordination of Fraud Prevention (UCLAF) and the Food and Veter- 15. 4. 98 ‹ EN ‹ Official Journal of the European Communities L 113/35 inary Office of the Commission that there are de- ficiencies in official controls on production of beef in the United Kingdom for dispatch to other Member States and third countries; whereas it is, therefore, necessary to reinforce the system of veteri- nary checks in order to prevent fraud; (25) Whereas reinforced checks should apply to all commercial consignments of fresh meat of bovine animals moving into, through or from the territory of the United Kingdom; whereas it is appropriate to require that all such consignments be sealed and unsealed by the competent authority and accom- panied by veterinary certificates and, in the case of intra-Community trade, to require an official noti- fication of the dispatch of a consignment by means of the ANIMO system as referred to in Commission Decision 91/398/EEC of 19 July 1991 on a compu- terised authorities (ANIMO) (1), or by fax; veterinary network linking (26) Whereas the veterinary supervision of the processing of meat derived from bovine animals slaughtered elsewhere than in the United Kingdom should also be reinforced; (27) Whereas the United Kingdom put forward a first proposal for an export certified herds scheme to the the Commission on 25 February 1997; whereas Scientific Veterinary Committee concluded at its meeting of 11 June 1997 that that proposal was not adequate; whereas the United Kingdom put forward a modified proposal dated 1 July 1997; whereas the Scientific Veterinary Committee issued an opinion on that revised proposal on 17 September 1997 stating that the major obstacle to approving the the United the entire territory of scheme for Kingdom was the lack of a comprehensive compu- terised movement and tracing system and associated database for live cattle in Great Britain but that an adequate system did apear in Northern Ireland; whereas the Committee concluded further- more that small modifications could be made to minor aspects of the scheme at the request of the competent Commission departments to comply with certification or control requirements; whereas the Food and Veterinary Office conducted a feasibility inspection in Northern Ireland from 3 to 7 November 1997; whereas the United Kingdom has agreed to further improvements in line with the inspection; recommendations made following that whereas, therefore, a partial lifting of the prohibition in order to exist on the dispatch of products from bovine animals slaughtered in Northern Ireland is appropriate; (28) Whereas inspections carried out by the Commission services have shown that the system of veterinary checks effective; in Northern Ireland is more whereas, therefore, a step-by-step approach is appro- priate, starting with the lifting of the prohibitions on the dispatch of products from bovine animals slaughtered, cut, processed and stored in establish- ments exclusively used for products destined for dispatch to other Member States and third countries, located in Northern Ireland; whereas subsequent steps will include the lifting of the prohibition on the processing of eligible meat from Northern Ireland in Great Britain, under conditions which will be laid down at a later stage: whereas the Commis- immediately start investigating, with the sion will authorities of the United Kingdom, by what means and under what conditions those restrictions may be further relaxed; (29) Whereas in order to prevent fraud, meat derived from bovine animals slaughtered in the United Kingdom should bear, in addition to the health mark provided for in Article 3(1)(A)(e) of Council Directive 64/433/EEC of 26 June 1964 on health problems affecting intra-Community trade in fresh meat (2), a distinct mark which cannot be confused with the Community health mark; (30) Whereas most of the provisions of Decision 94/474/EC are no longer in conformity with the opinion of the Scientific Veterinary Committee of 17 September 1997 and should therefore be deleted; (31) Whereas Decision 96/239/EC required the United Kingdom to provide reports on the BSE situation every two weeks; whereas that period has been found to be too short; whereas it should be extended to one month; (32) Whereas the Commission should continue to carry out Community inspections in the United Kingdom to verify the application of the measures provided for in this Decision; (33) Whereas the foregoing entails a fundamental re- in the working of Decision 96/239/EC; whereas, interests of clarity, that Decision should be repealed; (34) Whereas this Decision will be reviewed in the light of new scientific information; (1) OJ L 221, 9. 8. 1991, p. 30. (2) OJ 121, 29. 7. 1964, p. 2012/64. Directive as last amended by Directive 95/23/EC (OJ L 243, 11. 10. 1995, p. 7). L 113/36 ‹ EN ‹ Official Journal of the European Communities 15. 4. 98 (35) Whereas the Standing Veterinary Committee has not Article 4 given a favourable opinion, HAS ADOPTED THIS DECISION: CHAPTER I Live bovine animals, bovine embryos, meat-and- bone meal and related products Article 1 the situation, and Pending an overall examination of notwithstanding Community provisions to adopted protect against BSE, the United Kingdom shall ensure that the following are not dispatched from its territory to other Member States or to third countries: (a) live bovine animals and bovine embryos; (b) meat meal, bone meal, and meat-and-bone meal of mammalian origin; (c) animal feed and fertilisers containing material referred to in (b). Article 2 By way of derogation from Article 1, food destined for domestic carnivores containing material referred to in Article 1(b) may be dispatched to other Member States or to third countries provided that those materials did not originate from the United Kingdom and that the condi- tions laid down in Articles 9 and 10 are complied with. CHAPTER II Materials derived from bovine animals slaughtered in the United Kingdom Article 3 the situation, and Pending an overall examination of notwithstanding Community provisions to adopted protect against BSE, the United Kingdom shall ensure that the following are not dispatched from its territory to other Member States or to third countries, when derived from bovine animals slaughtered in the United Kingdom: (a) meat; 1. By way of derogation from Article 3, the United Kingdom may authorise the production and the dispatch from its territory to other Member States or to third coun- tries of: (a) amino acids, peptides and tallow, which have been produced in establishments under official veterinary supervision which have been shown to be operating in accordance with the conditions set out in Annex I; (b) tallow products and products derived from tallow by saponification, transesterification or hydrolysis, where these are manufactured from tallow produced in ac- cordance with this Article. The United Kingdom shall ensure that the products 2. referred to in paragraph 1 are labelled or otherwise iden- tified to show the establishment of production and to in- dicate that they are suitable for use in human food, animal feed, cosmetics or medical or pharmaceutical products. 3. The United Kingdom shall ensure that products referred to in paragraph 1(a) which are dispatched to other Member States in accordance with this Article are accom- panied by a health certificate issued by an official veteri- narian stating that they conform to the conditions laid down in this Decision and attesting to the frequency of official controls carried out. 4. Before an establishment may commence or recom- mence the dispatch of products pursuant to this Article, the United Kingdom shall forward to the Commission and the other Member States the list of the establishments referred to in paragraph 1(a), identifying for each estab- lishment the purpose for which it has been approved. It shall notify the Commission and the other Member States immediately of any amendments to that list. 5. Community inspections shall be carried out on the implementation of official controls in respect of each of the products referred to in paragraph 1 before the dispatch of those products may commence or recom- mence. after having The Commission, 6. consulted the Member States in the framework of the Standing Vet- erinary Committee, shall set the date on which estab- lishments may commence or recommence dispatch of the products referred to in paragraph 1(a). Article 5 (b) products which are liable to enter the human food or animal feed chains; (c) materials which are destined for use in cosmetics or medical or pharmaceutical products. The United Kingdom shall ensure that gelatin, di-calcium phosphate, collagen, tallow, tallow products and products derived from tallow by saponification, transesterification or hydrolysis which are produced for technical use from raw materials derived from bovine animals slaughtered in 15. 4. 98 ‹ EN ‹ Official Journal of the European Communities L 113/37 the United Kingdom are labelled or otherwise identified to show the establishment of production and their un- suitability for use in human food, animal feed, cosmetics or medical or pharmaceutical products. Article 6 1. By way of derogation from Article 3, the United Kingdom may authorise the dispatch to other Member States or to third countries of the following products derived from bovine animals born and reared in Northern Ireland which have been slaughtered in Northern Ireland in slaughterhouses exclusively used for that purpose, in accordance with the conditions laid down in this Article, Article 7, Articles 9 to 12 and Annex II: (a) ‘fresh meat’ as defined by Directive 64/433/EEC; (b) ‘minced meat’ and ‘meat preparations’ as defined by Directive 94/65/EC (1); (c) ‘meat products’ as defined by Directive 77/99/EEC (2). tissues, The fresh meat referred to in paragraph 1(a) shall be 2. deboned and all adherent including obvious nervous and lyphatic tissues shall be removed in cutting plants in Northern Ireland, exclusively used for eligible products. Cold storage shall take place in Northern Ireland in chambers exclusively used for eligible products. Cutting, storage and transport shall be carried out in accordance with the conditions laid down in this Article, Article 7, Articles 9 to 12 and Annex II. The fresh meat referred to in paragraph 1(a) may be 3. used for the production of products referred to in para- graph 1(b) and (c) in establishments in Northern Ireland exclusively used for eligible products, in accordance with the conditions laid down in this Article, in Article 7, Articles 9 to 12 and Annex II. 4. For the purposes of this Article, eligible products means products referred to in paragraph 1 and products derived from bovine animals not slaughtered in the United Kingdom which comply with the conditions laid down in Articles 9 to 13. 5. The Commission, after having carried out Com- munity inspections and after having informed the Mem- ber States, shall set the date on which dispatch of the products referred to in paragraph 1 may commence. 6. The Commission shall review the provisions of this Article at least every three months and shall take appro- priate measures in accordance with the procedure laid down in Article 18 of Directive 89/662/EEC. Article 7 1. The meat and products referred to in Article 6(1) shall be marked or labelled with an additional distinct mark which cannot be confused with the Community health mark. (1) OJ L 368, 31. 12. 1994, p. 10. (2) OJ L 26, 31. 1. 1977, p. 85. 2. Meat and products as referred to in Article 6(1) which are destined for placing on the market in the United Kingdom shall not bear the additional mark referred to in paragraph 1 of this Article. Where such a mark is present, it shall be cancelled or removed from the meat or cancelled from the label at the time that meat or those products leave the establishment. The Community health mark shall not be removed except where that is unavoidable in the cutting process. 3. The United Kingdom shall forward to the Commis- sion and the other Member States the model of the addi- tional mark referred to in paragraph 1 before dispatch commences. CHAPTER III Materials derived from bovine animals not slaught- ered in the United Kingdom Article 8 The United Kingdom shall ensure that the provisions of Articles 9 to 13 are complied with when the following products derived from bovine animals not slaughtered in the United Kingdom are dispatched from its territory to other Member States or to third countries: (a) ‘fresh meat’ as defined by Directive 64/433/EEC; (b) ‘minced meat’ and ‘meat preparations’ as defined by Directive 94/65/EC; (c) ‘meat products’ and ‘other products of animal origin’ as defined by Directive 77/99/EEC; (d) food which is destined for domestic carnivores; tallow, (e) gelatin and di-calcium phosphate, tallow products, and products derived from tallow by saponi- fication, transesterification or hydrolysis, amino acids, peptides and collagen which are liable to enter the human food or animal feed chains, or are destined for use in cosmetics or medical or pharmaceutical products. Article 9 1. The products referred to in Article 8 shall come from and, as appropriate, have passed through, establish- ments in the United Kingdom: (a) which have been approved by the comptetent au- thority; (b) which are under official veterinary supervision or, in the case of products derived from tallow by saponifica- tion, transesterification or hydrolysis, under the super- vision of the competent authority; L 113/38 ‹ EN ‹ Official Journal of the European Communities 15. 4. 98 (c) which have put in place a system of tracing the raw material which will guarantee the origin of the ma- terial throughout the whole production chain; (d) which have put in place a registration system of amounts of incoming and outgoing materials to allow for cross-checking consignments entering or leaving; (e) in which the products are unloaded, processed, stored, handled, loaded and transported separately from, or at different times from, products which do not comply with the conditions laid down in this Article and Articles 10, 11 and 12. 2. The United Kingdom shall forward to the Commis- sion and the other Member States the list of establish- ments which meet the conditions referred to in paragraph 1, the purpose for which it has been approved. It shall notify the Commis- sion and the Member States immediately of any amend- ments to that list. identifying for each establishment Article 10 1. Products referred to in Article 8(a) to (d) shall come from and, as appropriate, have passed through estab- lishments in the United Kingdom in which: (a) all unloading, processing, storage or other handling and loading of products takes place under official supervision; (b) the products are stored in cold stores in chambers which are not used at the same time for storing any bovine products which do not comply with the condi- tions laid down in this Article, in Articles 9, 11, 12 and 13 and are kept locked under the seal of the competent authority when the latter is not present; (c) the products, with the exception of the products referred to in Article 8(d), are marked or labelled with an additional distinct mark which cannot be confused with the Community health mark; (d) the products eligible for dispatch from the United Kingdom within the meaning of this Article and Articles 9, 11, 12 and 13, but destined for placing on the market in the United Kingdom do not bear the additional mark referred to in point (c). Where such a mark is present, it shall be cancelled or removed from the meat or cancelled from the label at the time that meat or those products leave the establishment. 2. For the purposes of the health marking and applica- tion of additional marks provided for in Community legislation, the competent authority shall keep and main- tain under its responsibility: (a) the instruments intended for meat health marking and application of additional marks, which may be handed over to auxiliaries only at time of marking and for the length of time required for that purpose; (b) any labels bearing a health mark or an additional mark. Those labels shall be serially numbered and the requisite quantity may be given to auxiliaries at the time when they are to be used. 3. The products referred to in paragraph 1 shall be transported by means of transport that are sealed by the competent authority. When those products are dispatched to other Member States, they shall be accompanied by a health certificate issued by an official veterinarian stating that the condi- tions referred to in this Article and Articles 9, 11, 12 and 13 are met, identifying all establishments where they were obtained, processed, handled or stored and identifying all labels and their serial numbers in the consignment. Meat shall be accompanied by the health certificate referred to in Annex IV to Directive 64/433/EEC identi- fying in the ‘Identification of Meat’ section of the certi- ficate all labels and their serial numbers in the consign- ment. The following words shall be added to all certificates: ‘produced in accordance with Decision 98/256/EC’. 4. The United Kingdom shall inform the competent authority of the place of destination of each consignment by means of the Animo system or by fax. Article 11 Without prejudice to Article 7(2) and Article 10(1)(d), where products referred to in Article 8(a) come from and, as appropriate, have passed through establishments in the United Kingdom, the Community health marks shall not be removed except where that is unavoidable in the cutting process. Article 12 The United Kingdom shall forward to the Commission and the other Member States the model of the additional mark. referred to in Article 8(e) which are The products dispatched to other Member States shall be labelled in order to identify the establishment of production and to indicate that they have been produced in accordance with 15. 4. 98 ‹ EN ‹ Official Journal of the European Communities L 113/39 this Decision and, as appropriate, that they are suitable for use in human food, animal feed, cosmetics or medical or pharmaceutical products. Article 13 1. A Member State which dispatches meat as referred to in Article 8(a) from an establishment or Community approved border inspection post in its territory through the territory of the United Kingdom or to an establish- ment approved in accordance with Article 9 shall ensure that the meat is accompanied by a veterinary certificate issued by an official veterinarian or the certificate issued by the competent authority of the border inspection post. The originals of all certificates shall accompany the consignment to the establishment of its destination. The meat as referred to in Article 8(a) shall be trans- 2. ported in an officially sealed vehicle. The seal may be broken only for official purposes. inspection 3. A Member State which dispatches products referred to in Article 8(e) or any raw materials for use in the production of to an establishment approved in accordance with Article 9 shall ensure that they are labelled or otherwise identified to show the es- tablishment and Member State in which they were produced. those products CHAPTER IV Final provisions Article 14 Article 15 The United Kingdom shall send the Commission every month a report on the application of the protective measures taken against BSE, in accordance with national and Community provisions. Article 16 This Decision shall be reviewed regularly in the light of new scientific information. This Decision shall be amended, where appropriate, after consultation of the appropriate Scientific Committee, in accordance with the procedure of Directive 89/662/EEC. laid down in Article 18 Article 17 Member States shall adopt comply with this Decision. They shall inform the Commission thereof. the necessary measures to immediately Article 18 Decision 94/474/EC is hereby amended as follows: 1. Article 1 shall be deleted; 2. in Article 3, paragraphs 1 and 2 shall be deleted; 3. Article 4 shall be deleted. Article 19 Decision 96/239/EC is hereby repealed. Article 20 This Decision is addressed to the Member States. Done at Brussels, 16 March 1998. The Commission shall carry out Community inspections on-the-spot in the United Kingdom to verify the applica- tion of the provisions of this Decision, in particular in relation to the implementation of official controls. For the Council The President J. CUNNINGHAM L 113/40 ‹ EN ‹ Official Journal of the European Communities 15. 4. 98 ANNEX I CHAPTER 1 1. The following products may be exported from the United Kingdom by virtue of Articles 4 to 7: (a) amino acids and peptides produced from hides and skins by a process which involves exposure of the material to a pH of 1 to 2, followed by a pH of ;11, followed by heat treatment at 140 HC for 30 minutes at 3 bar; (b) tallow and tallow products produced from material from animals fit for human consumption which has been subjected to one of the processes described in Chapter 2; (c) products derived from tallow by one of the processes described in Chapter 3. 2. Products referred to in point 1 must be filtered after production. 3. Bovine animals which are showing signs of BSE and animals over 30 months of age may not be used as source materials (as provided for by Commission Regulation (EC) No 716/96) (1) for production of the products referred to in point 1. 4. The following tissues may not be used for production of products referred to in point 1: skull, vertebral column, brain, spinal cord, eye, tonsil, thymus, intestine or spleen. CHAPTER 2 A. Production standards for tallow produced in the United Kingdom from material derived from bovine animals slaughtered in the United Kingdom 1. Tallow may be produced only in systems described in Chapters I to IV, VI and VII of the Annex to Commission Decision 92/562/EEC (2), in which the following minimum conditions are achieved: CHAPTER I (Batch/atmospheric/natural fat) 150 mm particle size maximum CHAPTER II Temperature Time ; 100 HC ; 110 HC ; 120 HC 120 min 125 min 50 min (Batch/pressure/natural fat) 50 mm particle size maximum ; 100 HC ; 133 HC Temperature 25 min Time Pressure (absolute) 3 bar 20 min CHAPTER III (Continuous/atmospheric/natural fat) 30 mm particle size maximum Temperature Time ; 100 HC ; 110 HC ; 120 HC 55 min 95 min 13 min CHAPTER IV and VI (Continuous/atmospheric/added fat and continuous/pressure/added fat) 30 mm particle size maximum Temperature Time ; 100 HC ; 110 HC ; 120 HC ; 130 HC 16 min 13 min 8 min 3 min CHAPTER VII (Continuous/atmospheric/defatted) 20 mm particle size maximum Temperature Time ; 80 HC ; 100 HC 120 min 60 min The above temperature/time requirements may run concurrently. (1) OJ L 99, 20. 4. 1996, p. 14. (2) OJ L 359, 9. 12. 1992, p. 23. 15. 4. 98 ‹ EN ‹ Official Journal of the European Communities L 113/41 2. The United Kingdom may authorise plants only if they have been shown by methods laid down in Section B to be operating in accordance with the conditions set out in point 1. 3. Batch systems which achieve the parameters laid down in point 2 for continuous systems operating in accordance with Chapters III, IV, VI or VII may also be authorised. B. Procedures for the validation of plants for the processing of animal waste of ruminant origin for the production of tallow in the United Kingdom, using methods described in the Annex to Decision 92/562/EEC 1. Temperature — continuous and batch systems Temperature monitoring devices must be situated regularly throughout the equipment in order to record temperature at different stages in the process. Records should be kept and calibrations completed at regular intervals. 2. Pressure (Chapter II only) Pressure monitoring devices must be installed in order to record pressure at stages in the process. Records must be kept and calibrations completed at regular intervals. 3. Particle size — all systems CHAPTER 3 Human food, animal feed, medical or pharmaceutical products, their starting materials or inter- mediate products Tallow derivatives may be used provided that they are produced by an appropriate, validated and strictly certified method such as: 1. 2. transesterification or hydrolysis at not less than 200 HC for not less than 20 minutes under pressure (glycerol, fatty acids and fatty acid esters production); or, saponification with NaOH 12M (glycerol and soap production): — in a batch process: at not less than 95 HC for not less than three hours; or, — in a continuous process: at not less than 140 HC, 2 bars for not less than eight minutes, or equivalent. Cosmetic products, starting materials or intermediate products Tallow derivatives may be used provided that the following methods have been used and strictly certified by the producer: 1. 2. transesterification or hydrolysis at at least 200 HC, 40 bars for 20 minutes (glycerol and fatty acids and esters); or, saponification with NaOH 12M (glycerol and soap): — in a batch process: at 95 HC for three hours; or, — in a continuous process: at 140 HC, 2 bars for eight minutes or equivalent. L 113/42 ‹ EN ‹ Official Journal of the European Communities 15. 4. 98 ANNEX II 1. Deboned fresh meat and products referred to in Article 6(1)(b) and (c) from that meat derived from bovine animals slaughtered in Northern Ireland may be dispatched from Northern Ireland in applica- tion of the provisions of Article 6 when obtained from eligible animals which originate from eligible herds. Eligible herds 2. A herd is a group of animals forming a separate and distinct unit, that is a group of animals which were managed, housed and kept separately from any other group of animals and which were identified with unique herd and animal identification numbers. 3. A herd is eligible when for at least 8 years, there has been no confirmed case of BSE, nor a suspect case for which the diagnosis of BSE has not been ruled out, in any animal which was still in or had moved through or from the herd. 4. As an exception to the provisions in point 2, a herd that has been in existence for less than eight years may be considered eligible, after a thorough epidemiological investigation by the competent veterinary authority, on condition that: (a) all animals born or moved into the newly established herd complied with the conditions set out in point 6(a), (c), (d) and (e); and, (b) the herd has complied with the conditions set out in point 3 during its entire existence. 5. If a herd is newly established on a holding which experienced a confirmed case of BSE in any animal which was still in or had moved through or from a herd on that holding, the newly established herd can only be eligible after a thorough epidemiological investigation by the competent veterinary authority, taking into account compliance with each of the following conditions to the satisfaction of the com- petent veterinary authority: (a) all animals of the affected herd have been removed or killed; (b) all feed has been removed and destroyed and all feed containers thoroughly cleansed; (c) all buildings have been emptied and thoroughly cleansed before the new animals were admitted; (d) all conditions set out in point 4 have been complied with. Eligible animals 6. A bovine animal is eligible if it has been born and reared in Northern Ireland and at the time of slaughter: (a) all records of its birth, identity and movements are recorded on an official computerised tracing system; (b) it is more than six months but less than 30 months of age, determined by reference to an official computer record of its date of birth; (c) its dam has lived for at least six months after its birth; (d) its dam has not developed BSE and is not suspected of having contracted BSE; (e) the herd of birth of the animal and all herds through which it has ever moved are eligible. 7. The official computerised tracing system referred to in point 6(a) will be accepted only where it has been in operation for sufficient time to contain all the information relating to the lifetime and movements of the animals needed to check compliance with the requirements of this Decision, and only in respect of animals born after the system came into operation. Historical data loaded into a computer for any period before the system was operational will not be accepted for this purpose. Controls 8. If animal presented for slaughter or any circumstance surrounding its slaughter does not meet all of the requirements of this Decision, the animal must be automatically rejected. If that information becomes available after slaughter, the competent authority must immediately cease issuing certificates, and cancel issued certificates. If dispatch has already taken place, the competent authority must notify the com- petent authority of the place of destination. The competent authority of the place of destination must take the appropriate measures. 15. 4. 98 ‹ EN ‹ Official Journal of the European Communities L 113/43 9. Slaughter of eligible animals must take place in slaughterhouses exclusively used for that purpose. Cutting, deboning and processing must place in establishments exclusively used for products which are eligible for dispatch to other Member States or third countries. Cold storage must take place in cham- bers, exclusively used for products which are eligible for dispatch to other Member States or third coun- tries. All establishments through which the products pass before such dispatch must be situated in Northern Ireland. 10. The competent authority must ensure that procedures used in the cutting plants ensure that the fol- lowing lymph nodes have been removed: — popliteal, ischiatic, superficial inguinal, deep inguinal, medial and lateral iliac, renal prefemoral, lumbar, costocervical, sternal, prescapular, axilliary and caudal deep cervical. 11. Meat must be traceable back to the herd of the eligible animal by means of the computerised tracing system until the time of slaughter. After slaughter, labels must be capable of tracing fresh meat and products referred to in Article 6(1)(b) and (c) back to the herd to enable the consignment concerned to be recalled. 12. All approved eligible carcases must have individual numbers correlated with the ear tag number. 13. The United Kingdom must have detailed protocols in place covering: (a) tracing and controls prior to slaughter; (b) controls during slaughter; (c) all labelling and certification requirements after slaughter to the point of sale. 14. The competent authority must set up a system for recording checks on compliance so that control can be demonstrated. The establishment 15. To obtain approval, the establishment must, in addition to all other requirements of this Decision, devise and implement a system whereby the eligible meat and/or eligible product is identifiable and all meat or products can be traced back to its herds of origin. The system must facilitate full traceability of the meat of products at all stages and records must be retained for at least two years. Details of the system to be employed must be given, in writing, by the management of the establishment to the competent au- thority. 16. The competent authority must assess, approve and monitor the system provided by the establishment in order to ensure that it provides full segregation and traceability both backwards and forwards